Yes. Vaccine development and clinical trials are a key research priority for COVID-19 in Africa. Voluntary clinical trials for COVID-19 vaccines continue to take place in Kenya and South Africa. Testing vaccines in Africa ensures that data is generated on the safety and efficacy of promising vaccines for the African population.
These are not the first vaccines to be tested in Africa, with vaccines like the conjugate meningitis A and Ebola vaccines having been tested on the continent before their rollout.
All clinical trials for COVID-19 vaccines are voluntary. Hundreds of thousands of people have been involved in clinical trials around the world, which has provided crucial data to help show that COVID-19 vaccines work and are safe.